» Articles » PMID: 21177435

HIF1alpha Synergizes with Glucocorticoids to Promote BFU-E Progenitor Self-renewal

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2010 Dec 24
PMID 21177435
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

With the aim of finding small molecules that stimulate erythropoiesis earlier than erythropoietin and that enhance erythroid colony-forming unit (CFU-E) production, we studied the mechanism by which glucocorticoids increase CFU-E formation. Using erythroid burst-forming unit (BFU-E) and CFU-E progenitors purified by a new technique, we demonstrate that glucocorticoids stimulate the earliest (BFU-E) progenitors to undergo limited self-renewal, which increases formation of CFU-E cells > 20-fold. Interestingly, glucocorticoids induce expression of genes in BFU-E cells that contain promoter regions highly enriched for hypoxia-induced factor 1α (HIF1α) binding sites. This suggests activation of HIF1α may enhance or replace the effect of glucocorticoids on BFU-E self-renewal. Indeed, HIF1α activation by a prolyl hydroxylase inhibitor (PHI) synergizes with glucocorticoids and enhances production of CFU-Es 170-fold. Because PHIs are able to increase erythroblast production at very low concentrations of glucocorticoids, PHI-induced stimulation of BFU-E progenitors thus represents a conceptually new therapeutic window for treating erythropoietin-resistant anemia.

Citing Articles

BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling.

Wu S, Deng Y, Sun H, Liu X, Zhou S, Zhao H Signal Transduct Target Ther. 2024; 9(1):338.

PMID: 39617757 PMC: 11609275. DOI: 10.1038/s41392-024-02033-6.


Lenalidomide-induced pure red cell aplasia is associated with elevated expression of MHC-I molecules on erythrocytes.

Hu Q, Liu Y, Yue Q, Zhou S, Jin X, Lin F Nat Commun. 2024; 15(1):10131.

PMID: 39578482 PMC: 11584757. DOI: 10.1038/s41467-024-54571-w.


Immunoregulation role of the erythroid cells.

Niu C, Zhang J Front Immunol. 2024; 15:1466669.

PMID: 39474425 PMC: 11518727. DOI: 10.3389/fimmu.2024.1466669.


Targeting the glucocorticoid receptor-CCR8 axis mediated bone marrow T cell sequestration enhances infiltration of anti-tumor T cells in intracranial cancers.

Zhang J, Shi Y, Xue X, Bu W, Li Y, Yang T Cell Mol Immunol. 2024; 21(10):1145-1157.

PMID: 39044027 PMC: 11442575. DOI: 10.1038/s41423-024-01202-5.


Global Transcriptomic and Characteristics Comparisons between Mouse Fetal Liver and Bone Marrow Definitive Erythropoiesis.

Gao C, Zhang H, Wang Y, Wang S, Guo X, Han Y Cells. 2024; 13(13.

PMID: 38995000 PMC: 11240549. DOI: 10.3390/cells13131149.


References
1.
Nijhof W, Wierenga P . Isolation and characterization of the erythroid progenitor cell: CFU-E. J Cell Biol. 1983; 96(2):386-92. PMC: 2112306. DOI: 10.1083/jcb.96.2.386. View

2.
Chabot B, Stephenson D, Chapman V, Besmer P, Bernstein A . The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature. 1988; 335(6185):88-9. DOI: 10.1038/335088a0. View

3.
Minamishima Y, Kaelin Jr W . Reactivation of hepatic EPO synthesis in mice after PHD loss. Science. 2010; 329(5990):407. PMC: 3668543. DOI: 10.1126/science.1192811. View

4.
So A, Chaivorapol C, Bolton E, Li H, Yamamoto K . Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet. 2007; 3(6):e94. PMC: 1904358. DOI: 10.1371/journal.pgen.0030094. View

5.
West K, Johnson P, KYRIAKOPOULOS A, BAHR W, BLOEDOW C . The physiologic effects of dexamethasone. Arthritis Rheum. 1960; 3:129-39. DOI: 10.1002/art.1780030204. View